Relmada Therapeutics Inc Intrinsic Valuation and Fundamental Analysis - Relmada Therapeutics Inc

	Relmada Therapeutics Inc F:4E2	US
O	One Enterprise PCL SET:ONEE	TH
S	Standard Chartered PLC DUS:STD	UK
S	Salesforce Inc F:FOO	US
B	BlackRock Inc XMUN:BLQA	US
C	Capital One Financial Corp XMUN:CFX	US
T	Thaire Life Assurance PCL SET:THREL	TH
L	L'Oreal SA XMUN:LORA	FR
C	Christian Dior SE XMUN:DIO	FR
	Atlas Copco AB F:ACO	SE

Intrinsic Value

The intrinsic value for Relmada Therapeutics Inc (4E2) under the Base Case is hidden EUR. Compared with the current market price of 4.6 EUR, the stock appears hidden .

Intrinsic value calculated using DCF

Locked

Other reference points

Multiples estimate

Locked

Wall St target

€4.74

Do our valuations actually work? See backtest results .

Relmada Therapeutics Inc Intrinsic Value

Unlock

Track Buy Zone

20% below Intrinsic Value

Get notified when the price drops into your buy zone

Current Price €4.6

Intrinsic Value Locked

Margin of Safety 20% Locked

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Relmada Therapeutics Inc looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether Relmada Therapeutics Inc usually does or if today's premium is unusual.

See where today’s valuation sits in Relmada Therapeutics Inc’s own history and what typically happened over the next 12 months after similar periods.

Show Historical Valuation

What is Valuation History?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Relmada Therapeutics Inc.

Explain Valuation